Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia

Korean Journal of Internal Medicine

Volumn 26, Issue 2, 2011, Pages 195-200

  Ha, Young Eun ^a   Kang, Cheol In ^a   Joo, Eun Jeong ^a   Joung, Mi Kyong ^a   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Song, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bacteremia; C reactive protein; Liver cirrhosis; Treatment outcome

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; BLOODSTREAM INFECTION; COMORBIDITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; END STAGE LIVER DISEASE; ESCHERICHIA COLI INFECTION; FEMALE; HEALTH CARE; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959824171     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2011.26.2.195     Document Type: Article

References (16)

1. Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med 1966;123:365-378.
2. Park WB, Lee KD, Lee CS, et al. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis 2005;51:227-230.
3. Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intensive Care Med 2006;32:1344-1351.
4. Le Moine O, Deviere J, Devaster JM, et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol 1994;20:819-824.
5. Povoa P, Coelho L, Almeida E, et al. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005;40:1855-1857.
6. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005;11:101-108.
7. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008;121:219-225.
8. Coelho L, Povoa P, Almeida E, et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 2007;11:R92.
9. Povoa P, Coelho L, Almeida E, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005;25:804-812.
10. Verhagen DW, Hermanides J, Korevaar JC, et al. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008;168:302-307.
11. Friedman ND, Kaye KS, Stout JE, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-797.
12. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628-637.
13. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
14. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
15. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11:7-12.
16. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-155.